Thermo Fisher Scientific introduces the next generation Thermo Scientific™ Vanquish™ Charged Aerosol Detector P Series for more sensitive detection of impurities

June 16, 2025

 

  

WALTHAM, MA, June 16, 2025 – Thermo Fisher Scientific introduces the next generation Thermo Scientific™ Vanquish™ Charged Aerosol Detector P Series for more sensitive detection of impurities   

  

Image:   

A machine with a white background with Willis Tower in the background

AI-generated content may be incorrect., Picture, Picture  

Overview:  

Thermo Fisher Scientific has introduced the enhanced Thermo Scientific™ Vanquish™ Charged Aerosol Detector (CAD) P Series, an innovation to improve the analysis of the most complex samples, even those with analytes that do not possess chromophores. For those working in drug safety testing and new drug modality development, the Vanquish CAD P Series plays a crucial role in proving the quality and stability of products, helping support the safety and purity of therapies entering the market. By simplifying workflows, supporting regulatory-compliant workflows and improving quantitative accuracy, the Vanquish CAD P Series helps laboratories achieve reliable results faster to drive performance, confidence and convenience in daily analytical testing.  

  

"As an early adopter of the Charged Aerosol Detector, I am pleased with the reliability and advancements the technology provides us with for developing efficient HPLC methods that aim to enhance drug safety. My students really enjoy working with this technology, and we look forward to our next publication focused on results obtained using the new detector,” shared Professor Jim Grinias, Ph.D., Department of Chemistry & Biochemistry, Rowan University.  

  

The new model delivers improved application-dependent sensitivity compared to the existing model, while a new temperature coupling mode improves detection of semi-volatile compounds to get the complete picture of the sample components. Other enhancements of the Vanquish CAD P Series simplify onboarding, operation and optimization of processes, providing a reliable and reproducible detection solution for use in any lab.  

  

"We are proud to introduce the next evolution of the Vanquish Charged Aerosol Detector, a milestone that builds upon our decades of CAD technology experience,” said Nicky Burbidge, vice president and general manager, High Performance Chromatography Solutions, Thermo Fisher. “The new CAD offers higher sensitivity than previous versions and remains the obvious choice when deciding between other detection methods such as ELSD and RID for difficult to detect compounds. This universal detector launch supports our Mission to enable our customers make the world healthier,cleanerand safer."  

   

  

Key Applications:  

The Vanquish CAD P Series addresses the need for higher precision, improved reproducibility and sensitivity in near-universal detection within pharmaceutical and biopharmaceutical labs, as well as in food and beverage, and fine chemical industries. The innovation delivers critical insights into quantity of hard-to-detect analytes and ultimately the quality of products.  

  

Features/Benefits:  

Enhanced sensitivity: Delivers better detection of impurities next to high concentration analytes in one run by higher signal height with similar noise (application dependent) compared to current products.  

For example, measurement of cholic acid and its impurity showed approximately 30 percent improvement.  

  

Flexible configuration: The temperature coupling mode offers users the option to fine tune thermostatting parameters for more sensitivity in semi-volatile detection.   

  

Improved robustness: The diverter valve and temperature coupling mode minimize the risk of contamination within the analytes path through the detector, ensuring high quality analysis each time.  

  

Optimized operating conditions: Users can record up to four power value signals in parallel to find optimized settings for their calibration curve and enhance the linear range response.  

  

  

Web Site:  

  

thermofisher.com/CADpseries   

  

  

  

  

  

About Thermo Fisher Scientific  

  

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of more than $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com